Lavenburg Linda-Marie U, Devaraj Susan M, Gul Ambreen, Weltman Melanie R, Kenkre Balchandre Neilesh, de Abril Cameron Flor, Schell Jane O, Hamm Megan E, Jhamb Manisha
Renal-Electrolyte Division, University of Pittsburgh Medical Center, Pittsburgh, PA.
Department of Pharmacy & Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA.
Kidney Med. 2025 May 15;7(7):101025. doi: 10.1016/j.xkme.2025.101025. eCollection 2025 Jul.
RATIONALE & OBJECTIVE: A population health management intervention for a pragmatic cluster randomized control trial (Kidney CHAMP) aimed to improve care and outcomes in patients with chronic kidney disease (CKD) at high-risk of progression to dialysis dependence but not seeing a nephrologist. The Kidney CHAMP intervention provided comanagement support to primary care providers by nephrology electronic-consult, pharmacist-directed medication reconciliation, and nurse-delivered CKD patient education. We sought to learn patient perceptions of Kidney CHAMP intervention and whether the intervention improved their understanding of CKD.
An ancillary study of Kidney CHAMP using qualitative methods.
SETTING & PARTICIPANTS: Participants were sampled from Kidney CHAMP intervention group using 3 predefined strata (racial/ethnic minorities, low socioeconomic status, and multimorbidities) from May 2021 to February 2022.
We conducted semistructured televideo or telephone interviews that were transcribed and then inductively coded by 2 data analysts until thematic saturation was reached. Conventional content and thematic analyses were performed.
In 45 patient interviews (mean age 75 ± 8 years, 44% women, 9% non-White race, and 59% low socioeconomic status), we identified 4 themes. First, patients expressed support for CKD comanagement by the primary care providers (PCPs) and nephrology team. Second, education sessions had variable effect on improving patients'understanding of CKD and its health implications. Third, patients' self-efficacy and understanding of CKD management varied and was influenced by their understanding of its health implications. Fourth, patients appreciated education sessions and wanted more frequent sessions and actionable individualized guidance.
Low representation of non-White individuals, recall bias, and lack of validated measures for health literacy, patient knowledge, and activation.
Patients with CKD who are managed by their PCP were supportive of remote comanagement by a nephrologist. Patients perceive some aspects of CKD health education to be beneficial; however, more effective approaches to communicating risk of CKD development and progression are needed.
一项针对实用型整群随机对照试验(肾脏CHAMP)的人群健康管理干预措施,旨在改善有进展为透析依赖高风险但未就诊于肾病科医生的慢性肾脏病(CKD)患者的护理及预后。肾脏CHAMP干预措施通过肾脏科电子会诊、药剂师指导的药物重整以及护士提供的CKD患者教育,为初级保健提供者提供共同管理支持。我们试图了解患者对肾脏CHAMP干预措施的看法,以及该干预措施是否提高了他们对CKD的认识。
采用定性方法对肾脏CHAMP进行的一项辅助研究。
2021年5月至2022年2月期间,从肾脏CHAMP干预组中按照3个预定义分层(种族/族裔少数群体、低社会经济地位和多种疾病)抽取参与者。
我们进行了半结构化电视视频或电话访谈,访谈内容被转录,然后由2名数据分析人员进行归纳编码,直至达到主题饱和。进行了常规内容分析和主题分析。
在45例患者访谈中(平均年龄75±8岁,44%为女性,9%为非白人种族,59%为低社会经济地位),我们确定了4个主题。第一,患者对初级保健提供者(PCP)和肾脏科团队的CKD共同管理表示支持。第二,教育课程对提高患者对CKD及其健康影响的理解效果不一。第三,患者的自我效能感和对CKD管理的理解各不相同,并受到他们对其健康影响理解的影响。第四,患者赞赏教育课程,并希望课程更频繁且有可操作的个性化指导。
非白人个体代表性低、回忆偏倚以及缺乏针对健康素养、患者知识和激活的有效测量方法。
由其初级保健提供者管理的CKD患者支持肾病科医生进行远程共同管理。患者认为CKD健康教育的某些方面有益;然而,需要更有效的方法来传达CKD发生和进展的风险。